Skip to content

13F-HR filed by Logos Global Management LP

Logos Global Management LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 15:23:13 UTC, with 72 holding rows worth $1,856,293,550.

Accession
0001172661-26-005128
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 72 entries on the cover page, a total value of $1,856,293,550 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,856,293,550 with VALUE read as dollars as filed, 13F file number 028-20025. A later restatement replaced it, so the quarter does not use it. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
PRAXIS PRECISION MEDICINES I74006W207COM NEW425,000$123,772,750dollars as filed
REVOLUTION MEDICINES INC COM76155X100Stock600,000$123,156,000dollars as filed
IDEAYA BIOSCIENCES INC COM45166A102Stock2,850,000$109,497,000dollars as filed
ERASCA INC COM29479A108Stock5,900,000$86,494,000dollars as filed
ABIVAX SA-00370M103SPONSORED ADS870,000$86,147,400dollars as filed
CG ONCOLOGY INC156944100COMMON STOCK975,000$69,117,750dollars as filed
DISC MEDICINE INC COM254604101Stock1,015,000$66,441,900dollars as filed
BIONTECH SE SPONSORED ADS09075V102ADR650,000$63,895,000dollars as filed
TANGO THERAPEUTICS INC87583X109COM2,150,000$53,642,500dollars as filed
MADRIGAL PHARMACEUTICALS INC COM558868105Stock100,000$50,396,000dollars as filed
ENLIVEN THERAPEUTICS INC COM29337E102Stock1,080,000$49,507,200dollars as filed
DYNE THERAPEUTICS INC COM26818M108Stock3,000,000$48,330,000dollars as filed
OCULAR THERAPEUTIX INC67576A100COM6,000,000$46,020,000dollars as filed
DIANTHUS THERAPEUTICS INC252828108COM500,000$44,025,000dollars as filed
ARRIVENT BIOPHARMA INC04272N102COM1,350,000$40,878,000dollars as filed
COGENT BIOSCIENCES INC19240Q201COM1,250,000$40,025,000dollars as filed
ERASCA INC COM29479A108Stock2,500,000$36,650,000dollars as filedcall
NEUROCRINE BIOSCIENCES INC64125C109COM250,000$35,460,000dollars as filed
BELITE BIO INC07782B104CMN200,000$33,964,000dollars as filed
AXSOME THERAPEUTICS INC. COM05464T104Stock175,000$32,268,250dollars as filed
STRUCTURE THERAPEUTICS INC COMP86366E106EQUITY1,000,000$31,270,000dollars as filed
OLEMA PHARMACEUTICALS INC68062P106COM3,208,875$27,724,680dollars as filed
ACHIEVE LIFE SCIENCES INC004468500COMMON STOCK3,200,000$25,888,000dollars as filed
MAZE THERAPEUTICS INC COM578784100Stock935,000$25,413,300dollars as filed
PARABILIS MEDICINES INC COM698955101Stock750,000$24,217,500dollars as filed
APNIMED INC03770Y107COM1,100,000$24,101,000dollars as filed
Yarrow Bioscience, Inc.92941V407Common Stock, $0.0001 par value1,026,258$23,111,330dollars as filed
AVALO THERAPEUTICS INC05338F306COMMON STOCK1,500,000$22,995,000dollars as filedcall
TREVI THERAPEUTICS INC COM89532M101Stock1,445,000$20,692,400dollars as filed
VERADERMICS INC922967104COMMON STOCK170,000$20,609,100dollars as filed
REPLIMUNE GROUP INC76029N106COMMON STOCK1,500,000$19,860,000dollars as filedcall
VERA THERAPEUTICS INC92337R101COMMON STOCK600,000$19,374,000dollars as filed
DESIGN THERAPEUTICS INC25056L103COM1,500,000$18,855,000dollars as filedcall
SAREPTA THERAPEUTICS INC803607100COM1,000,000$18,220,000dollars as filed
SAREPTA THERAPEUTICS INC803607100COM1,000,000$18,220,000dollars as filedcall
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD61559X104Stock1,500,000$17,550,000dollars as filed
SUMMIT THERAPEUTICS INC86627T108COM1,000,000$16,910,000dollars as filedcall
IMMUNOCORE HLDGS PLC ADS45258D105ADR500,000$15,145,000dollars as filed
BIOHAVEN LTDG1110E107COM1,100,000$14,685,000dollars as filed
CRISPR THERAPEUTICS AG NAMEN AKTH17182108Stock250,000$13,830,000dollars as filed
BIOHAVEN LTDG1110E107COM1,000,000$13,350,000dollars as filedcall
DEFINIUM THERAPEUTICS INC24477V105COM SHS350,000$13,321,000dollars as filed
ARCUS BIOSCIENCES INC03969F109COM500,000$12,915,000dollars as filedcall
ENTERA BIO LTDM40527109SHS4,411,764$12,838,233dollars as filed
DESIGN THERAPEUTICS INC25056L103COM1,000,000$12,570,000dollars as filed
COMPASS PATHWAYS PLC20451W101SPONSORED ADS1,000,000$12,440,000dollars as filedcall
CRESCENT BIOPHARMA INCG2545C104COMMON STOCK850,000$12,401,500dollars as filed
Electra Therapeutics, Inc.284825106Common Stock, $0.0001 par value per share1,000,000$11,250,000dollars as filed
MINERVA NEUROSCIENCES INC603380205COM NEW3,288,777$11,017,403dollars as filed
LB PHARMACEUTICALS INC50180M108COMMON STOCK250,000$9,595,000dollars as filed
ACHIEVE LIFE SCIENCES INC004468500COMMON STOCK1,000,000$8,090,000dollars as filedcall
ALUMIS INC022307102COM1,000,000$7,390,000dollars as filedcall
INVENTIVA SA46124U107ADS2,000,000$7,380,000dollars as filedcall
EYEPOINT INC COM NEW30233G209Stock2,000,000$6,540,000dollars as filedcall
VIKING THERAPEUTICS INC92686J106COM200,000$6,520,000dollars as filed
EDITAS MEDICINE INC28106W103COM2,222,000$5,710,540dollars as filed
TONIX PHARMACEUTICALS HOLDIN890260839COMMON STOCK550,000$5,357,000dollars as filed
OPUS GENETICS INC67577R102COMMON STOCK1,000,000$4,840,000dollars as filed
VOGENX INC92859A106COM205,000$4,671,950dollars as filed
IMMUNOVANT INC45258J102COM85,000$2,871,300dollars as filed
JADE BIOSCIENCES INC008064206COM NEW200,000$2,810,000dollars as filed
ONKURE THERAPEUTICS INC68277Q105COM CL A963,855$2,626,505dollars as filed
TCGX ACQUISITION CORPG8708J109COM200,000$2,502,000dollars as filed
UNICYCIVE THERAPEUTICS INC90466Y202COMMON STOCK473,563$2,223,378dollars as filed
PALATIN TECHNOLOGIES INC696077601COM NEW129,260$1,146,536dollars as filed
JATT II ACQUISITION CORPG50765109ORD SHS100,000$1,124,500dollars as filed
JATT III ACQUISITION CORPG5080G109COM100,000$1,102,000dollars as filed
Research Alliance Corp Iii Ord Shs Cl AG75226103Common Stock100,000$1,083,000dollars as filed
SEPTERNA INC COM81734D104Stock23,548$921,433dollars as filed
AMANAT ACQUISITION CORPG0375M101CL A ORD50,000$534,000dollars as filed
Longeveron Inc54303L302COM192,308$517,309dollars as filed
FRACTYL HEALTH INC35168W103COM504,965$274,903dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001172661-26-005128this filing2026-11-16
13F-HR/A 0001172661-26-005476 base2026-11-19